Phase I/II Trial of Maintenance Therapy With Lenalidomide and Rituximab Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B-cell Non-Hodgkin Lymphoma.
Phase of Trial: Phase I/II
Latest Information Update: 27 Sep 2015
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab
- Indications B cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma
- Focus Adverse reactions; Biomarker; Pharmacogenomic
- 07 Jun 2017 Biomarkers information updated
- 23 Nov 2011 Actual patient number is 5 as reported by ClinicalTrials.gov.
- 23 Nov 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.